These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10414439)

  • 21. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism.
    Xu B; Xiao-hong L; Lin G; Queen L; Ferro A
    Br J Pharmacol; 2002 Jun; 136(3):375-82. PubMed ID: 12023940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
    Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R
    Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.
    Zhang X; Hintze TH
    Circulation; 1998 Feb; 97(6):576-80. PubMed ID: 9494028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat.
    Lubarsky SL; Ahokas RA; Friedman SA; Sibai BM
    Am J Obstet Gynecol; 1997 May; 176(5):1069-76. PubMed ID: 9166170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine limits infarct size via NO-dependent mechanisms in dogs.
    Asanuma H; Kitakaze M; Funaya H; Takashima S; Minamino T; Node K; Sakata Y; Asakura M; Sanada S; Shinozaki Y; Mori H; Kuzuya T; Tada M; Hori M
    Basic Res Cardiol; 2001 Sep; 96(5):497-505. PubMed ID: 11605997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
    Paulis L; Becker ST; Lucht K; Schwengel K; Slavic S; Kaschina E; Thöne-Reineke C; Dahlöf B; Baulmann J; Unger T; Steckelings UM
    Hypertension; 2012 Feb; 59(2):485-92. PubMed ID: 22215717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production.
    Wang WZ; Matsumori A; Yamada T; Shioi T; Okada I; Matsui S; Sato Y; Suzuki H; Shiota K; Sasayama S
    Circulation; 1997 Jan; 95(1):245-51. PubMed ID: 8994443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-NAME-induced protein remodeling and fibrosis in the rat heart.
    Pechánová O; Bernátová I; Pelouch V; Babál P
    Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
    Alvarez G; Osuna A; Wangensteen R; Vargas F
    Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM; Mostafa A; Al-Shabanah O
    Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.